HFSA

Heart pump placement plus anticoagulation suffice for patients, even those with Afib

Transplant surgeons discuss testing the concept in more humans

Analyses continue to support wider adoption of dapagliflozin, researchers say

It may be goodbye to priority tiers, hello to points-based ranking system in coming years

Cardiac ICU staffing issues require a multidisciplinary team approach, some say

A debate on where LVAD innovation stands

Agreement that non-invasive alternatives to EMB are not ready for routine rejection surveillance

Trial suggests hard outcomes not the only ones helped by this class of medication

Novel cardiac myosin inhibitor is headed for a phase III trial

Problems of implementation and health equity persist

Neurocognitive protection by sacubitril/valsartan suggested instead by observational study

Reduced GDMT titration suggests a dip in quality of care

Apnea indices, daytime sleepiness improved over 5 years

Inflammation, circadian rhythm, and beyond